APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are growing number of consumables for various spatial genomics and transcriptomics applications, introduction of novel products, and increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent.
The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.
“By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market”
Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.
“By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market”
Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
“China: the largest share of the spatial genomics & transcriptomics market”
China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.
“By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market”
Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.
“By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market”
Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
“China: the largest share of the spatial genomics & transcriptomics market”
China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 60% and Demand Side 40%
- By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
- By Country: Japan- 22%, China- 47%, India- 11%, Rest of APAC- 20%
- NanoString Technologies, Inc. (US)
- 10X Genomics (US)
- Illumina (US)
- Bio-Rad Laboratories (US)
- Bio-Techne Corporation (US)
- Standard BioTools Inc. (US)
- Genomic Vision SA (France)
- Akoya Biosciences, Inc. (US)
- S2 Genomics (US)
- Cantata Bio (US)
- Vizgen Group (US)
- BGI Group (China)
- Miltenyi Biotec (Germany)
- Bruker (US)
- Perkinelmer Inc. (US)
- Novogene Co., Ltd. (China)
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022?2027)
FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
4 PREMIUM INSIGHTS
4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW
FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021)
FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021)
FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Reduced cost of next-generation sequencing
5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for single-cell analysis
5.2.4 CHALLENGES
5.2.4.1 Analytical limitations associated with spatial techniques
5.3 TECHNOLOGY ANALYSIS
TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
5.4 VALUE CHAIN ANALYSIS
TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PRICING ANALYSIS
TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
5.8.1 AVERAGE SELLING PRICE TREND
5.9 KEY CONFERENCES AND EVENTS (2020–2023)
TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023)
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
FIGURE 20 KEY BUYING CRITERIA FOR END USERS
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY PRODUCT
6.1 INTRODUCTION
TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 SOFTWARE
6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE
7.1 INTRODUCTION
TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
7.2 SPATIAL TRANSCRIPTOMICS
TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 IMMUNOHISTOCHEMISTRY
7.2.1.1 Emergence of mIHC/IF to propel growth
TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 IN SITU HYBRIDIZATION
7.2.2.1 High adoption of MERFISH to drive growth
TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.1 Microdissection-based sequencing
7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
TABLE 18 ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 In situ sequencing
7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
TABLE 19 ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.3 Other sequencing technologies
TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.4 MICROSCOPY-BASED RNA IMAGING
7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
TABLE 21 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
TABLE 22 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SPATIAL GENOMICS ANALYSIS
TABLE 23 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 24 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
TABLE 25 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 SPATIAL GENOMIC SEQUENCING
7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
TABLE 26 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
TABLE 27 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY APPLICATION
8.1 INTRODUCTION
TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 TRANSLATIONAL RESEARCH
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 DRUG DISCOVERY AND DEVELOPMENT
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY END USER
9.1 INTRODUCTION
TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 ACADEMIC AND RESEARCH INSTITUTES
9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
TABLE 33 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
TABLE 34 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY COUNTRY
10.1 INTRODUCTION
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.2 CHINA
10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 37 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 38 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 41 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 JAPAN
10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 43 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 47 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 INDIA
10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 49 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 52 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 SINGAPORE
10.4.2.1 Active partnerships with key players to boost market growth
TABLE 54 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 55 SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 58 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 59 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 SOUTH KOREA
10.4.3.1 Government initiatives and strong R&D expenditure to propel demand for spatial solutions
TABLE 60 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 61 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 64 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 65 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Increasing adoption of spatial solutions by research institutions to propel growth
TABLE 66 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 67 AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 71 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 72 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 73 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 77 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)
11.4 MARKET SHARE ANALYSIS (2021)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
11.6 COMPETITIVE SCENARIO AND TRENDS
11.6.1 DEALS
TABLE 78 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
11.6.1.1 Product launches
TABLE 79 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
11.6.1.2 Other developments
TABLE 80 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products, Recent Developments, MnM View)*
12.1.1 NANOSTRING
TABLE 81 NANOSTRING: BUSINESS OVERVIEW
FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
12.1.2 10X GENOMICS
TABLE 82 10X GENOMICS: BUSINESS OVERVIEW
FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
12.1.3 ILLUMINA
TABLE 83 ILLUMINA: BUSINESS OVERVIEW
FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
12.1.4 BIO-RAD LABORATORIES, INC.
TABLE 84 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.5 BIO-TECHNE
TABLE 85 BIO-TECHNE: BUSINESS OVERVIEW
FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
12.1.6 STANDARD BIOTOOLS
TABLE 86 STANDARD BIOTOOLS: BUSINESS OVERVIEW
FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
12.1.7 AKOYA BIOSCIENCES
TABLE 87 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
12.1.8 S2 GENOMICS
TABLE 88 S2 GENOMICS: BUSINESS OVERVIEW
12.1.9 CANTATA BIO
TABLE 89 CANTATA BIO: BUSINESS OVERVIEW
12.1.10 VIZGEN CORP.
TABLE 90 VIZGEN: BUSINESS OVERVIEW
*Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 BGI GROUP
12.2.2 MILTENYI BIOTEC
12.2.3 BRUKER
12.2.4 PERKINELMER INC.
12.2.5 NOVOGENE CO., LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022?2027)
FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
4 PREMIUM INSIGHTS
4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW
FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021)
FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021)
FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Reduced cost of next-generation sequencing
5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
5.2.2 RESTRAINTS
5.2.2.1 High capital investments
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for single-cell analysis
5.2.4 CHALLENGES
5.2.4.1 Analytical limitations associated with spatial techniques
5.3 TECHNOLOGY ANALYSIS
TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
5.4 VALUE CHAIN ANALYSIS
TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PRICING ANALYSIS
TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
5.8.1 AVERAGE SELLING PRICE TREND
5.9 KEY CONFERENCES AND EVENTS (2020–2023)
TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023)
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
FIGURE 20 KEY BUYING CRITERIA FOR END USERS
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY PRODUCT
6.1 INTRODUCTION
TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 SOFTWARE
6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE
7.1 INTRODUCTION
TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
7.2 SPATIAL TRANSCRIPTOMICS
TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 IMMUNOHISTOCHEMISTRY
7.2.1.1 Emergence of mIHC/IF to propel growth
TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 IN SITU HYBRIDIZATION
7.2.2.1 High adoption of MERFISH to drive growth
TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.1 Microdissection-based sequencing
7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
TABLE 18 ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 In situ sequencing
7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
TABLE 19 ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.3 Other sequencing technologies
TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.4 MICROSCOPY-BASED RNA IMAGING
7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
TABLE 21 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
TABLE 22 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SPATIAL GENOMICS ANALYSIS
TABLE 23 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 24 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
TABLE 25 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 SPATIAL GENOMIC SEQUENCING
7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
TABLE 26 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
TABLE 27 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY APPLICATION
8.1 INTRODUCTION
TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 TRANSLATIONAL RESEARCH
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 DRUG DISCOVERY AND DEVELOPMENT
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY END USER
9.1 INTRODUCTION
TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 ACADEMIC AND RESEARCH INSTITUTES
9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
TABLE 33 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
TABLE 34 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY COUNTRY
10.1 INTRODUCTION
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.2 CHINA
10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 37 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 38 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 41 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 JAPAN
10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 43 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 47 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 INDIA
10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 49 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 52 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 SINGAPORE
10.4.2.1 Active partnerships with key players to boost market growth
TABLE 54 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 55 SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 58 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 59 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 SOUTH KOREA
10.4.3.1 Government initiatives and strong R&D expenditure to propel demand for spatial solutions
TABLE 60 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 61 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 64 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 65 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Increasing adoption of spatial solutions by research institutions to propel growth
TABLE 66 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 67 AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 71 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 72 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 73 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 77 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)
11.4 MARKET SHARE ANALYSIS (2021)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
11.6 COMPETITIVE SCENARIO AND TRENDS
11.6.1 DEALS
TABLE 78 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
11.6.1.1 Product launches
TABLE 79 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
11.6.1.2 Other developments
TABLE 80 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products, Recent Developments, MnM View)*
12.1.1 NANOSTRING
TABLE 81 NANOSTRING: BUSINESS OVERVIEW
FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
12.1.2 10X GENOMICS
TABLE 82 10X GENOMICS: BUSINESS OVERVIEW
FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
12.1.3 ILLUMINA
TABLE 83 ILLUMINA: BUSINESS OVERVIEW
FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
12.1.4 BIO-RAD LABORATORIES, INC.
TABLE 84 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.5 BIO-TECHNE
TABLE 85 BIO-TECHNE: BUSINESS OVERVIEW
FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
12.1.6 STANDARD BIOTOOLS
TABLE 86 STANDARD BIOTOOLS: BUSINESS OVERVIEW
FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
12.1.7 AKOYA BIOSCIENCES
TABLE 87 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
12.1.8 S2 GENOMICS
TABLE 88 S2 GENOMICS: BUSINESS OVERVIEW
12.1.9 CANTATA BIO
TABLE 89 CANTATA BIO: BUSINESS OVERVIEW
12.1.10 VIZGEN CORP.
TABLE 90 VIZGEN: BUSINESS OVERVIEW
*Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 BGI GROUP
12.2.2 MILTENYI BIOTEC
12.2.3 BRUKER
12.2.4 PERKINELMER INC.
12.2.5 NOVOGENE CO., LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
